Related Experiment Video
Updated: Sep 13, 2025

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications
Jinxin Tang1,2,3,4, Yan Zhuang1,4, Yibo Zhang1,4
1Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, 410011, China.
Abstract:
Necroptosis represents a distinct form of programmed cell death that exhibits characteristics of both necrosis and apoptosis. Due to its potential to activate anti-cancer immune responses, utilizing necroptosis to enhance immune activity within the tumor microenvironment has garnered significant attention. However, effectively regulating necroptosis in cancer remains a formidable challenge. Epigenetic, post-transcriptional and post-translational modifications are three primary mechanisms that alter molecular expression patterns without changing DNA sequence, playing crucial roles in cancer progression. While these modifications have been shown to significantly influence cancer development, their specific roles in regulating necroptosis in cancer have not been systematically elucidated. This review explores the role and mechanism of epigenetic, post-transcriptional and post-translational modification in the regulation of necroptosis in cancer, identifying potential regulatory targets and their therapeutic implications, thereby providing systematic theoretical support for necroptosis as an emerging target for cancer therapy.
Insights
This review explores how epigenetic, post-transcriptional, and post-translational modifications regulate necroptosis (programmed cell death) in cancer. Understanding these mechanisms offers new therapeutic targets for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Necroptosis is a programmed cell death pathway with anti-cancer immune potential.
- Regulating necroptosis for cancer therapy is challenging.
- Epigenetic, post-transcriptional, and post-translational modifications influence cancer but their role in necroptosis is unclear.
Purpose of the Study:
- To systematically review the role of epigenetic, post-transcriptional, and post-translational modifications in regulating necroptosis in cancer.
- To identify potential regulatory targets within these modification pathways.
- To discuss the therapeutic implications for cancer treatment.
Main Methods:
- Literature review focusing on molecular modifications and necroptosis in cancer.
- Analysis of mechanisms linking epigenetic, post-transcriptional, and post-translational modifications to necroptosis.
- Identification of key regulatory nodes and therapeutic targets.
Main Results:
- These modifications significantly impact cancer progression and necroptosis.
- Specific pathways and targets involved in regulating necroptosis have been identified.
- The interplay between these modifications and necroptosis offers promising therapeutic avenues.
Conclusions:
- Epigenetic, post-transcriptional, and post-translational modifications are critical regulators of necroptosis in cancer.
- Targeting these modifications presents a novel strategy for cancer therapy.
- Further research into these mechanisms will support necroptosis-based cancer treatments.
More Related Videos
03:37Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Epigenetic Regulation
X-chromosome...
Apoptosis
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Histone Modification
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...